These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37713696)

  • 1. Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Before Rasburicase Use for Tumor Lysis Syndrome.
    Lakra R; Grewal US; Ramadas P
    Am J Ther; 2023 Sep-Oct 01; 30(5):e465-e467. PubMed ID: 37713696
    [No Abstract]   [Full Text] [Related]  

  • 2. A perfect storm: Tumor lysis syndrome with rasburicase-induced methemoglobinemia in a G6PD deficient adult.
    Montgomery KW; Booth GS
    J Clin Apher; 2017 Feb; 32(1):62-63. PubMed ID: 27119769
    [No Abstract]   [Full Text] [Related]  

  • 3. Rasburicase-induced hemolytic anemia in previously undiagnosed G6PD deficiency.
    Ferguson D; Kovach AE
    Blood; 2018 Aug; 132(6):673. PubMed ID: 30093385
    [No Abstract]   [Full Text] [Related]  

  • 4. Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6- Phosphate Dehydrogenase Deficiency.
    Khan M; Paul S; Farooq S; Oo TH; Ramshesh P; Jain N
    Curr Drug Saf; 2017; 12(1):13-18. PubMed ID: 28078984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent Problem.
    Bachmann KF; Nebiker M; Johner C; Bregy R; Schaller A; Novak U; Jakob SM
    A A Pract; 2019 Feb; 12(4):96-98. PubMed ID: 30052534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result.
    Geraldino-Pardilla L; Sung D; Xu JZ; Shirazi M; Hod EA; Francis RO
    Rheumatology (Oxford); 2014 Dec; 53(12):2310-1. PubMed ID: 25224415
    [No Abstract]   [Full Text] [Related]  

  • 7. Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.
    Bontant T; Le Garrec S; Avran D; Dauger S
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25115783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalase deficiency may complicate urate oxidase (rasburicase) therapy.
    Góth L; Bigler NW
    Free Radic Res; 2007 Sep; 41(9):953-5. PubMed ID: 17729111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rasburicase in the prevention and treatment of tumour lysis syndrome.
    Mayne N; Keady S; Thacker M
    Intensive Crit Care Nurs; 2008 Feb; 24(1):59-62. PubMed ID: 17698360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegloticase-Associated Hemolysis.
    Minshar MA; Osman-Malik Y; Bhat ZY
    Am J Ther; 2019; 26(5):e622-e624. PubMed ID: 30211701
    [No Abstract]   [Full Text] [Related]  

  • 11. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency.
    Cheah CY; Lew TE; Seymour JF; Burbury K
    Acta Haematol; 2013; 130(4):254-9. PubMed ID: 23860572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of tumor lysis syndrome management in a quaternary care hospital.
    Eng S; Lee CS; Ahn S; Sharma A
    J Oncol Pharm Pract; 2020 Mar; 26(2):338-344. PubMed ID: 31088218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout.
    Cammalleri L; Malaguarnera M
    Int J Med Sci; 2007 Mar; 4(2):83-93. PubMed ID: 17396159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase.
    Sonbol MB; Yadav H; Vaidya R; Rana V; Witzig TE
    Am J Hematol; 2013 Feb; 88(2):152-4. PubMed ID: 22573495
    [No Abstract]   [Full Text] [Related]  

  • 15. Single 6-mg dose of rasburicase: The experience in a large academic medical center.
    Nauffal M; Redd R; Ni J; Stone RM; DeAngelo DJ; McDonnell AM
    J Oncol Pharm Pract; 2019 Sep; 25(6):1349-1356. PubMed ID: 30111244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rasburicase-induced methaemoglobinaemia and G6PD deficiency in an unusual suspect.
    Oluwasanjo A; Alese O; Swierczynski S; Forman D
    Br J Haematol; 2015 Sep; 170(5):595. PubMed ID: 26033222
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe Tumor Lysis Syndrome in a Patient With Pancreatic Adenocarcinoma.
    Kolin M; Ben-Shahar M; Lapin O; Goldberg H
    Pancreas; 2016 Apr; 45(4):e12-3. PubMed ID: 26954496
    [No Abstract]   [Full Text] [Related]  

  • 18. Brisk clinical response to erythrocytapheresis in a G6PD-deficient patient with rasburicase-induced methemoglobinemia.
    Cooling L
    J Clin Apher; 2017 Dec; 32(6):599-600. PubMed ID: 28370399
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of tumour lysis syndrome in children: what is the evidence for prophylactic rasburicase in non-hyperleucocytic leukaemia?
    Agrawal AK; Feusner JH
    Br J Haematol; 2011 Apr; 153(2):275-7. PubMed ID: 21255003
    [No Abstract]   [Full Text] [Related]  

  • 20. I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency.
    Reeves DJ; Saum LM; Birhiray R
    Am J Health Syst Pharm; 2016 May; 73(9):e238-42. PubMed ID: 27099330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.